Medical device & digital health consultingFrance · International
H.B.T Group France
FREN
Let's talk about your project
Transforming healthcare. Anticipating tomorrow.

From innovation
to adoption,
from treatment to prevention

H.B.T Group France supports medical device and digital health stakeholders through their transformations, from defining their strategy to the practical adoption of innovations and technologies in the field.

Explore our expertiseWho are we?
Globe from the H.B.T Group France logo
International healthcare consulting
International healthcare consulting
Strategy. Execution. Clinical impact. Business model

Partners and clients

  • Infor
  • DELL Technologies
  • INeS - Institute for Smarthealth
  • SoFIA-Santé
  • Institut Astrium
  • SCC
  • Spondylus
  • Pgasus Partner
  • Telemedicine Technologies S.A.S
  • Bucci Industries
  • Femtech France
  • SNITEM
  • GRADeS ieSS
  • RegenLab
  • Hubert33 Consulting
Our expertise

From strategy to impact in healthcare.

We help healthcare stakeholders make innovation a genuine driver of transformation, from initial strategic directions through to real-world use.

By your side, from vision to execution

Innovation fulfils its purpose when it transforms practice.

We support healthcare stakeholders in turning their ambitions into practical solutions, combining market understanding, a command of regulatory and technological environments, and knowledge of real-world use.

Talk to our team
01

Commercial strategy, R&D and operations

Turning an innovation into a market opportunity requires alignment between the value proposition, clinical evidence, development priorities and business model. Our work covers positioning, market and target segmentation, pricing strategy, and the alignment of R&D, clinical and regulatory roadmaps with commercial objectives. Implementation then relies on governance and indicators that enable performance, adoption, quality and timelines to be managed.

Key deliverables: market and competitive analysis, segmentation and value proposition, business case and pricing strategy, R&D and clinical roadmap, go-to-market strategy, operating model and performance dashboard.

02

Managing complex, high-value projects

Programmes combining medical technologies, software and artificial intelligence, health data and clinical challenges require rigorous coordination, particularly in multi-site, multi-stakeholder environments. Governance, responsibilities, critical milestones, risks and budgets are structured to secure execution and effectively coordinate internal teams, technology partners, suppliers, contract research organisations (CROs), healthcare institutions, pilot sites and authorities. The objective is to manage the transition from project to large-scale deployment, on time and to the expected quality standards.

Key deliverables: project charter, risk mapping and mitigation plans, detailed schedule and milestones, executive progress reports, large-scale deployment plan.

03

Executive advisory and leadership support

Growth and transformation require clear decisions on strategic priorities, investment, organisational structure and funding pathways. Support for leaders, executive committees and boards of directors helps strengthen the clinical and economic value proposition, align governance and organisation, and translate strategic directions into operational decisions. Particular attention is paid to performance management and change management.

Key deliverables: 18–36-month strategic plan, transformation roadmap, governance and management dashboard, business case and funding pathway, investor materials and value proposition presentation, change management and internal/external communication plan.

04

Regulatory compliance and market access

Regulatory strategy and market access must be integrated from the earliest stages of development rather than treated as constraints at the end of the process. Quality management systems, clinical evaluation, technical documentation, cybersecurity and data protection are aligned with the requirements of target markets. This approach also incorporates reimbursement and health economic value, alongside post-market surveillance, to secure lasting compliance and market access.

Key deliverables: multi-market regulatory strategy, quality management system, technical documentation and clinical evaluation protocols, market access and reimbursement strategy, clinical and health economic evaluation dossiers, post-market surveillance plan and safety and compliance indicators.

05

Organising scientific and strategic events

Conferences, advisory boards, workshops and meetings of decision-makers become genuine drivers of influence and transformation when they address clear objectives: sharing knowledge, bringing expertise into dialogue, building consensus, bringing stakeholders together or accelerating the adoption of an innovation. From programme design to delivery, each event combines scientific governance, engagement of experts and decision-makers, content production, communication and operational excellence, with the ambition of extending its impact beyond the event itself.

Key deliverables: event concept and positioning, programme and scientific governance, speaker selection and coordination, scientific content and materials, communication and dissemination plan, operational management, impact report and post-event roadmap.

Hicham Temsamani
FounderHicham Temsamani
Our approach

Understand the ecosystem. Act in the field.

H.B.T Group France advocates the informed and considered adoption of digital health technologies. We support stakeholders across the ecosystem in turning innovation into useful, relevant and sustainable solutions, serving professionals, patients and the transformation of healthcare systems.

Strategic vision

Clarify market, positioning and development choices to build a value-creating path forward.

Operational excellence

Turn strategy into action by aligning teams, governance, resources and execution.

Regulatory expertise

Integrate regulatory, clinical and market access requirements into strategic decisions from the outset.

Informed and considered adoption

Assess technology in terms of its clinical value, usefulness and real-world applications to foster relevant and sustainable adoption.

Events & meetings

Sharing the ideas that matter.

H.B.T Group France helps bring scientific, medical and digital communities together.

Upcoming events(1)

  • From to

    Prevention & Longevity Conference — 3rd edition

    Maison de la Chimie, 28 rue Saint Dominique, Paris

    The 3rd edition of the Prevention & Longevity Conference will take place on 4 and 5 February 2027 at the Maison de la Chimie in Paris, in a hybrid format combining in-person and remote participation. Over two days, scientific experts, healthcare professionals, industry representatives, public-sector decision-makers and innovators will discuss three major themes: ultra-personalised prevention and longevity, women's health, and digital surgery and preventive medicine. This edition will also feature a prestigious official dinner bringing together key stakeholders from the ecosystem, alongside a startup competition showcasing the most promising innovations.

    Learn more

Past events(9)

Past events — dates retained for archival purposes.

  • 1st Congress of the Francophone Society for Artificial Intelligence in Healthcare

    Beaune

    The first congress of the Francophone Society for Artificial Intelligence in Healthcare will bring together experts and professionals to explore advances in AI in medicine. The event will focus on ethics, clinical integration and the future prospects of AI in healthcare.

    Learn more

  • National Embedded Systems Day — 8th edition

    National School of Applied Sciences, Kenitra, Morocco

    A scientific and technological event focused on embedded systems, artificial intelligence, the Internet of Things (IoT) and robotics.

    Learn more

    Documents and videos

  • From to

    Santexpo 2026

    PARIS EXPO PORTE DE VERSAILLES

    In 2026, the healthcare ecosystem's flagship exhibition celebrates six decades of innovation, debate and meetings.

    Learn more

  • First National Conference on eHealth in Nursing Homes

    Maison de la Chimie, 28 Rue Saint Dominique, Paris, 75007

    1st national conference on eHealth in nursing homes (EHPADs).

    Learn more

  • Prevention & Longevity Conference — 2nd edition

    Maison de la Chimie, 28 rue Saint Dominique, Paris

    On 5 February 2026 at the Maison de la Chimie in Paris, the 2nd edition of the conference “Prevention & Longevity: Building Tomorrow's Healthcare System” brought together practitioners, researchers, institutional representatives and innovation stakeholders around a common objective: accelerating the transition towards medicine that is more preventive, personalised and focused on longevity. At the heart of the discussions: ▪ Clinical advances in prevention: genomics, biological clocks, pharmacogenetics, nephrogenomics, ▪ Technological innovations in healthcare: artificial intelligence, biomarkers, digital twins, health data, ▪ Healthcare system transformation: population-level prevention, care organisation, societal challenges.

    Learn more

    Talks and recap videos

  • From to

    AI4Health 2025 — Oncology and digital twins: shared foundations for treatment and prevention?

    Grand Palais, Avenue Winston Churchill, Paris, France

    Panel discussion: oncology and digital twins — shared foundations for treatment and prevention?

    Talks and recap videos

  • Regional eHealth Meetings, GRADeS ieSS PACA

    CHIS Toulon, 54 Rue Henri Sainte-Claire Deville, Toulon, 83100

    A key opportunity to advance healthcare coordination together. On the programme: Challenges and solutions for strengthening coordination between community and hospital care: the importance of establishing a human organisational framework, suitable digital tools and their reproducibility in other regions. Management through the lens of care pathways: how can we improve pathway monitoring and prevent gaps in care? The regional Intelligent Health and Social Care Directory: our teams will present this new tool, followed by feedback from care coordination support services (DACs).

    Learn more

  • Prevention & Longevity Conference — 1st edition

    Maison de la Chimie, 28 rue Saint Dominique, Paris.

    On 4 April 2025, the Maison de la Chimie in Paris hosted the first edition of the Prevention & Longevity Conference, bringing together experts, decision-makers and key healthcare stakeholders around a common objective: rethinking the healthcare system by placing prevention at the heart of practice. Organised by H.B.T Group France, the event explored advances in ultra-personalised preventive medicine, the integration of connected technologies, remote monitoring and AI, as well as the human, societal and economic challenges of such a transformation.

    Learn more

    Talks and recap videos

  • From to

    AI & Oncology Workshop

    CHU Agadir Souss Massa, Agadir, 80000, Morocco

    • Talks: 1- Building and sustaining an oncology big data resource, 2- A competency framework for AI in healthcare, • Organisation and facilitation of a telemedicine workshop: from design to evaluation — methodology and best practice

    Learn more
Read

Perspectives on healthcare transformation.

In-depth topics at the intersection of technology, organisations and real-world use.

Prevention & Longevity

Prevention & Longevity Conference 2027: “Model and Act”, a New Ambition to Transform Healthcare

On 4 and 5 February 2027, the Maison de la Chimie in Paris will host the 3rd edition of the Prevention & Longevity Conference. Guided by the new motto “Model and Act”, this edition will explore three major themes: ultra-personalised prevention and longevity, women's health and digital surgery. The programme includes two days of scientific discussions in a hybrid format, an innovation competition for startups and a prestigious official dinner. A renewed ambition: to accelerate the transition towards more preventive, personalised medicine that is accessible to everyone.

Read the article
Healthcare System Transformation & Digital Health

Tomorrow’s Healthcare: From Treatment to Prevention, the Urgent Need for a Paradigm Shift

Faced with the surge in chronic diseases and the limitations of the treatment-focused model, the transition towards preventive and personalised medicine is becoming a necessity. Genomics, biomarkers, artificial intelligence and health data are opening new opportunities to anticipate risks and improve healthy longevity. But this transformation requires much more than technological innovation: it calls for a redesign of funding models, progressively prioritising prevention over hospitalisation. An essential paradigm shift to build a more humane, accessible and economically sustainable healthcare system.

Read the article
Artificial intelligence

AI in French healthcare: the real debate begins with data architecture

The real obstacle to deploying artificial intelligence in healthcare is not technological but structural. Fragmented data, a lack of interoperability and sovereignty concerns still limit its potential. Whether through centralised or distributed architectures, transforming the healthcare system depends first on reliable, secure and accessible data infrastructure. This is a major strategic challenge if AI is to become a genuine driver of innovation, prevention and better care.

Read the article
Prevention & health literacy

Health literacy: the missing link in the transition to a preventive health system

Faced with an ageing population and the rise in chronic diseases, France must accelerate its transition towards preventive, personalised medicine that is accessible to everyone. But this transformation cannot succeed without strengthening health literacy, which is essential to enable every citizen to understand their risks, make informed choices and take action for their health. A major challenge for equity, sustainability and long-term political vision.

Read the article
An issue to move forward?

Let's talk about what your innovation can change.

Tell us about your challenge. We would be delighted to start a conversation.

Go to the contact page